EXECUTIVE DIRECTOR, THERAPEUTIC STRATEGY LEAD, RARE DISEASE (WORLDWIDE CLINICAL TRIALS)
Derek Ansel has worked in clinical research for more than ten years with a focus almost exclusively in rare and pediatric diseases, including non-malignant hematology, autoimmune diseases, metabolic disorders, movement disorders, and other genetic conditions. At Worldwide, he leads and supports corporate initiatives within rare and pediatric diseases and maintains relationships with over 45 patient-focused advocacy organizations.
1:00 PM - 2:00 PM
Monday, June 5